Frequent adverse events during prolonged Bedaquiline treatment on XDR-tuberculosis patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021
Differences in symptoms that precede an exacerbation that influence treatment decisions Source: Annual Congress 2008 - COPD Year: 2008
Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period Source: Eur Respir J 2003; 22: Suppl. 45, 150s Year: 2003
Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Possible erroneous classification of asthma severity as a result of non-compliance Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Integrated care pathways significantly reduce drug dosing and administration errors in patients with acute asthma Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006
Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
The risk factors of the TB death among case of initial treatment failure and retreatment after default Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Predictable adverse events such as respiratory depression highlight the need for caution when prescribing morphine for refractory breathlessness Source: Eur Respir J, 50 (3) 1701357; 10.1183/13993003.01357-2017 Year: 2017
Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study Source: Eur Respir J, 53 (5) 1802161; 10.1183/13993003.02161-2018 Year: 2019
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death? Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020 Year: 2021
The main causes which lead to immediate and belated failure in tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 141s Year: 2005
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Source: Eur Respir J 2016; 48: 1268-1270 Year: 2016
Dose omission to shorten methacholine challenge testing: clinical consequences and safety of the use of a "10% fall in FEV1" threshold Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018
Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy Source: Eur Respir J 2004; 24: Suppl. 48, 188s Year: 2004
Digital airflow measurement early in treatment course for spontaneous pneumothorax predicting surgical referral Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018